Preclinical study of the domestic cord blood stem cell drug "Cryocel"
- Authors: Surkov K.G.1, Belova L.A.1, Krasniakov V.K.1
-
Affiliations:
- All-Russian Scientific Center for the Safety of Biologically Active Substances [VNC BAS]
- Issue: No 1 (2006)
- Pages: 74-77
- Section: Original Study Articles
- URL: https://genescells.ru/2313-1829/article/view/126778
- DOI: https://doi.org/10.23868/gc126778
- ID: 126778
Cite item
Abstract
The article presents the results of studying the effect of the domestic drug Cryocell on the course of ischemic stroke and acute myocardial infarction in an experiment.
Keywords
Full Text

About the authors
K. G. Surkov
All-Russian Scientific Center for the Safety of Biologically Active Substances [VNC BAS]
Author for correspondence.
Email: redaktor@celltranspl.ru
ГУЗ «Городская станция переливания крови»
Russian Federation, Saint-PetersburgL. A. Belova
All-Russian Scientific Center for the Safety of Biologically Active Substances [VNC BAS]
Email: redaktor@celltranspl.ru
ГУЗ «Городская станция переливания крови»
Russian Federation, Saint-PetersburgV. K. Krasniakov
All-Russian Scientific Center for the Safety of Biologically Active Substances [VNC BAS]
Email: redaktor@celltranspl.ru
ГУЗ «Городская станция переливания крови»
Russian Federation, Saint-PetersburgReferences
- Strauer В.Е., Brehm М„ Zeus T. et al. Repair of infarcted myocardium by autologous intracoronary mononuclear bone marrow cell transplantation in humans. Circulation 2002; 106[15): 1913-8.
- Chen J., Li Y., Katakowski M. et al. Intravenous bone marrow stromal cell therapy reduces apoptosis and promotes endogenous cell proliferation after stroke in female rat. J. Neurosci. Res. 2003; 73[6): 778-86.
- Willing A.E., Vendrame M„ Mallery J. et al. Mobilized peripheral blood cells administered intravenously produce functional recovery in stroke. Cell Transplant. 2003; 12(4): 449-54.
- Арзамасцев E.B. и др. Методические указания по экспериментальному изучению препаратов для лечения нарушений мозгового кровообращений. Руководство по экспериментальному [доклиническому) изучению новых фармакологических веществ. М„ 2000: 159-61.
- Menzies S.A., Hoff J.T., Betz A.L. Middle cerebral artery occlusion in rats: a neurological and pathological evaluation of a reproducible model. Neurosurgery 1992; 31(1): 100-6.
- Borlongan C.V., Hadman M„ Sanberg C.D., Sanberg P.R. Central nervous system entry of peripherally injected umbilical cord blood cells is not required for neuroprotection in stroke. Stroke 2004; 35(10): 2385-9.
- Chen J., Sanberg P.R., Li Y. et al. Intravenous administration of human umbilical cord blood reduces behavioral deficits after stroke in rats. Stroke 2001; 32(11): 2682-8.
- Vendrame M„ Cassady J., Newcomb J. et al. Infusion of human umbilical cord blood cells in a rat model of stroke dose-dependently rescues behavioral deficits and reduces infarct volume. Stroke 2004; 35(10): 2390-5.
- Willing A.E., Lixian J., Milliken M. et al. Intravenous versus intrastriatal cord blood administration in a rodent model of stroke. J. Neurosci. Res. 2003; 73(1): 296-307.
- Taguchi A. et al. Administration of CD 34+ cells after stroke enhances neurogenesis via angiogenesis in a mouse model. J. Clin. Invest. 2004; 114:330-8.
- Henning R.J. et al. Human umbilical cord blood mononuclear cells for the treatment of acute myocardial infarction. Cell Transplant. 2004; 13: 729-39.
- Hirata Y. et al. Human umbilical cord blood cells improve cardiac function after myocardial infarction. Biochem. Biophys. Res. Commun. 2005; 327:609-14.
- Yang C. et al. [Transplantation of cord blood endothelial progenitor cells ameliorates limbischemia] Zhonghua Yi Xue Za Zhi 2003; 83:1437-41 [Article in Chinese],
- Madeddu P. et al. Transplantation of low dose CD34+KDR+ cells promotes vascular and muscular regeneration in ischemic limbs. FASEB J 2004;18:1737
Supplementary files
